Our goals
Our lab is interested in cancer gene regulation, epigenetics and genomics with the following goals:
1. Identification of new cancer therapeutic targets;
|
2. Better understanding of molecular mechanisms and pathways underlying cancer progression;
|
3. Development of new cancer therapeutics and biomarkers.
|
09/09/2016: New paper published in Cell Death & Differentiation: Silencing the epigenetic silencer KDM4A for TRAIL and DR5 induction and antitumor therapy. Cell Death & Differentiation.[[1]]
view more news…
|
|